RealTime Dynamix™: Multiple Sclerosis US Q3 2017 Spotlight III

With the FDA approval and imminent shipping of Mylan’s generic glatiramer acetate (GA 20mg and 40mg) injections, pricing pressure will increase on Teva’s Copaxone and Sandoz’s Glatopa, the first-to-market generic GA 20mg, and payer pressure can be expected to markedly expand.

Click the button below to view highlights from this report:

Download Report Spotlight

2017-10-17T19:35:59+00:00